Barclays Upgrades Novartis AG (NVS)


Novartis AG (NYSE:NVS) was upgraded by research analysts at Barclays to an “equal weight” rating in a report released on Friday, Marketbeat.com reports.
Other institutional investors have recently added to or reduced their stakes in the company. Bremer Trust National Association boosted its position in Novartis AG by 10.2% in the fourth quarter. Bremer Trust National Association now owns 3,445 shares of the company’s stock worth $297,000 after buying an additional 319 shares during the period. Dividend Asset Capital boosted its position in Novartis AG by 4.1% in the fourth quarter. Dividend Asset Capital now owns 3,460 shares of the company’s stock worth $298,000 after buying an additional 137 shares during the period. Advisory Services Network LLC boosted its position in Novartis AG by 467.5% in the fourth quarter. Advisory Services Network LLC now owns 3,598 shares of the company’s stock worth $310,000 after buying an additional 2,964 shares during the period. Brookstone Capital Management boosted its position in Novartis AG by 5.8% in the fourth quarter. Brookstone Capital Management now owns 3,684 shares of the company’s stock worth $317,000 after buying an additional 203 shares during the period. Finally, Berkshire Asset Management boosted its position in Novartis AG by 21.8% in the fourth quarter. Berkshire Asset Management now owns 3,689 shares of the company’s stock worth $317,000 after buying an additional 661 shares during the period.

Week's Most Significant Insider Trades: January 22 - 26, 2018

Disposals: Cardinal Health Inc (NYSE:CAH) CEO Michael C. Kaufmann sold 18,586 shares of the business’s stock in a transaction tha...